Skip to main content

HistoRx Licenses AQUA Rights to Four Centers

NEW YORK (GenomeWeb News) — HistoRx yesterday said it has licensed its AQUA biomarker-analysis technology to four research institutes.
 
The non-commercial agreements went to Brigham and Women’s Hospital, the Mayo Clinic, the Lee Moffitt Cancer Center and Research Institute, and the University of Wisconsin-Madison’s School of Medicine and Public Health.
 
HistoRx said these institutes will use the platform to measure localization and concentration of clinically relevant proteins in diseased tissues, which will aid in developing drugs and in making treatment decisions.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.